此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

运动训练与维生素D代谢 (Hybri-D)

2026年11月4日 更新者:Dimitrios Draganidis、University of Thessaly

混合型高强度间歇训练对超重/肥胖成人维生素D代谢的影响

The prevalence of Vitamin D deficiency is significantly higher in adults with overweight/obesity compared to those with normal body mass index (BMI). The "entrapment" of Vitamin D in adipose tissue due to impaired lipolytic stimulation and/or adipose tissue dysfunction has been proposed as the driving mechanism. Exercise training has been proposed as a promising strategy to increase mobilization of Vitamin D from adipose tissue, given its well described role in stimulating lipolysis. Indeed, a recent study revealed that participation in moderate-intensity cardiovascular type exercise over winter can mitigate the decline in 25-hydroxyvitamin D [25(OH)D] in adults with overweight/obesity, independent of weight loss. The aim of this study is to investigate the impact of hybrid-type high-intensity interval training over winter on vitamin D metabolism, in adults with overweight/obesity.

研究概览

详细说明

Thirty adults with overweight/obesity (both males and females) who will meet the inclusion criteria will be randomly assigned to either an Exercise group (n=15) or a Control group (n=15). The Exercise group will participate in three hybrid-type high-intensity interval training sessions per week over a 12-week period, while receiving a balanced diet. The Control group will receive a balanced diet but will not participate in exercise training. Both groups will provide a resting blood sample and undergo assessment of their body composition (via bioelectrical impedance analysis), daily dietary intake (via dietary recalls) and physical activity level (via accelerometry) at baseline (prior to intervention), 6 weeks and 12 weeks.

研究类型

介入性

注册 (估计的)

30

阶段

  • 不适用

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习联系方式

  • 姓名:Dimitrios Draganidis, PhD
  • 电话号码:+302431047078
  • 邮箱:ddraganidis@uth.gr

研究联系人备份

  • 姓名:Ioannis G Fatouros, PhD
  • 电话号码:2431047047
  • 邮箱:ifatouros@uth.gr

学习地点

    • Karyes
      • Trikala、Karyes、希腊、42100
        • 招聘中
        • Department of Physical Education and Sport Science, University of Thessaly
        • 接触:
        • 接触:
          • Athanasios Z Jamurtas, PhD
          • 电话号码:2431047054
          • 邮箱:ajamurt@uth.gr
        • 副研究员:
          • Eytychia Giouvri, BSc

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

35年 至 50年 (成人)

接受健康志愿者

是的

有资格学习的性别

全部

描述

Inclusion Criteria:

  • BMI = 25-35 kg/m2
  • Absence of musculoskeletal injuries
  • Absence of chronic health-related complications
  • Non-smokers

Exclusion Criteria:

  • Consumption of Vitamin D supplements
  • Consumption of anti-inflammatory drugs, statins and/or steroids

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 主要用途:其他
  • 分配:随机化
  • 介入模型:并行分配
  • 屏蔽:无(打开标签)

武器和干预

参与者组/臂
干预/治疗
实验性的:Exercise group

Exercise group will participate in three hybrid-type high-intensity interval training sessions per week over a 12-week period, while receiving a balanced diet

Receive a balanced diet and participate in three hybrid-type high-intensity interval training sessions per week over a 12-week period

有源比较器:Control group

Control group will receive a balanced diet but will not participate in exercise training

Receive a balanced diet but abstain from any type of exercise training

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
Change in 25-hydroxyvitamin D concentration
大体时间:At baseline, 6 weeks and 12 weeks

25-OH-VD will be quantitatively determined in serum

At baseline, 6 weeks and 12 weeks
Change in plasma Vitamin D binding protein concentration
大体时间:At baseline, 6 weeks and 12 weeks

Vitamin D binding protein concentration will be determined in plasma

At baseline, 6 weeks and 12 weeks
Change in calcium concentration
大体时间:At baseline, 6 weeks and 12 weeks

Calcium concentration will be determined in serum

At baseline, 6 weeks and 12 weeks
Change in albumin concentration
大体时间:At baseline, 6 weeks and 12 weeks

Albumin concentration will be determined in serum

At baseline, 6 weeks and 12 weeks
Change in aspartate aminotransferase (SGOT) concentration
大体时间:At baseline, 6 weeks and 12 weeks

SGOT concentration will be determined in serum on a Clinical Chemistry analyzer

At baseline, 6 weeks and 12 weeks
Change in alanine aminotransferase (SGPT) concentration
大体时间:At baseline, 6 weeks and 12 weeks

SGPT concentration will be determined in serum on a Clinical Chemistry analyzer

At baseline, 6 weeks and 12 weeks
Change in gamma-glutamyl transferase (γ-GT) concentration
大体时间:At baseline, 6 weeks and 12 weeks

γ-GT concentration will be determined in serum on a Clinical Chemistry analyzer

At baseline, 6 weeks and 12 weeks

次要结果测量

结果测量
措施说明
大体时间
Change in reduced glutathione concentration
大体时间:At baseline, 6 weeks and 12 weeks

Reduced glutathione concentration will be determined in blood erythrocytes

At baseline, 6 weeks and 12 weeks
Change in oxidized glutathione concentration
大体时间:At baseline, 6 weeks and 12 weeks

Oxidized glutathione concentration will be determined in blood erythrocytes

At baseline, 6 weeks and 12 weeks
Change in dietary intake
大体时间:At baseline, 6 weeks and 12 weeks

Dietary intake habits will be assessed through dietary recalls

At baseline, 6 weeks and 12 weeks
Change in physical activity level
大体时间:At baseline, 6 weeks and 12 weeks

Physical activity will be assessed via accelerometry

At baseline, 6 weeks and 12 weeks
Change in body composition
大体时间:At baseline, 6 weeks and 12 weeks

Body composistion will be assessed via bioelectrical impedance analysis (BIA)

At baseline, 6 weeks and 12 weeks

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

调查人员

  • 首席研究员:Dimitrios Draganidis, PhD、University of Thessaly

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (实际的)

2025年11月1日

初级完成 (实际的)

2026年1月31日

研究完成 (估计的)

2026年12月15日

研究注册日期

首次提交

2025年12月9日

首先提交符合 QC 标准的

2025年12月9日

首次发布 (实际的)

2025年12月23日

研究记录更新

最后更新发布 (实际的)

2026年11月6日

上次提交的符合 QC 标准的更新

2026年11月4日

最后验证

2026年5月1日

更多信息

与本研究相关的术语

药物和器械信息、研究文件

研究美国 FDA 监管的药品

不

研究美国 FDA 监管的设备产品

不

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

订阅